These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 423925)

  • 41. Early diagnosis of Duchenne muscular dystrophy.
    Beckmann R; Sauer M; Ketelsen UP; Scheuerbrandt G
    Lancet; 1978 Jul; 2(8080):105. PubMed ID: 78271
    [No Abstract]   [Full Text] [Related]  

  • 42. Editorial: Screening of the newborn for Duchenne muscular dystrophy.
    Br Med J; 1975 May; 2(5968):403-4. PubMed ID: 1125555
    [No Abstract]   [Full Text] [Related]  

  • 43. Antenatal diagnosis of haemoglobinopathies, haemophilia, von Willebrand's disease, Duchenne's muscular dystrophy, and chronic granulomatous disease by fetal blood analysis.
    DeVore GR; Mahoney MJ; Hobbins JC
    Clin Obstet Gynaecol; 1980 Apr; 7(1):41-72. PubMed ID: 6155237
    [No Abstract]   [Full Text] [Related]  

  • 44. [Screening for Duchenne muscular dystrophy].
    Beckmann R
    Offentl Gesundheitswes; 1981 Sep; 43(9):414-20. PubMed ID: 6213887
    [No Abstract]   [Full Text] [Related]  

  • 45. A new screening test for serum creatine phosphokinase.
    Paterson Y
    Clin Chim Acta; 1971 Oct; 34(3):373-6. PubMed ID: 5119330
    [No Abstract]   [Full Text] [Related]  

  • 46. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
    Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on "activated" serum creatine phosphokinase in children].
    Sitzmann FC; Djayaputra M
    Klin Padiatr; 1972 Jan; 184(1):59-63. PubMed ID: 5063479
    [No Abstract]   [Full Text] [Related]  

  • 48. In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy in a female fetus "suddenly at risk".
    Evans MI; Farrell SA; Greb A; Ray P; Johnson MP; Hoffman EP
    Am J Med Genet; 1993 May; 46(3):309-12. PubMed ID: 8488877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Muscular dystrophy: some recent developments in research.
    Walton J
    Isr J Med Sci; 1977 Feb; 13(2):152-8. PubMed ID: 324948
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic counselling in neuromuscular diseases in Western Australia.
    Hurse PV; Kakulas BA
    Proc Aust Assoc Neurol; 1974; 11():145-53. PubMed ID: 4469625
    [No Abstract]   [Full Text] [Related]  

  • 51. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Errors in plasma creatine kinase estimations on fetal blood samples resulting from contamination with amniotic fluid and maternal blood: relevance for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(2):119-34. PubMed ID: 6739434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum creatine phosphokinase in normal newborns.
    Gilboa N; Swanson JR
    Arch Dis Child; 1976 Apr; 51(4):283-5. PubMed ID: 1275541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Steroid-CPK test. A new diagnostic aid for muscular dystrophy and its carriers?
    Sen S; Das PK
    Eur Neurol; 1978; 17(5):258-64. PubMed ID: 710453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid screening test for Duchenne muscular dystrophy using dried blood specimens.
    Orfanos AP; Naylor EW
    Clin Chim Acta; 1984 Apr; 138(3):267-74. PubMed ID: 6723063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duchenne muscular dystrophy: neonatal screening and prenatal diagnosis.
    Plauchu H; Dorche C; Cordier MP; Guibaud P; Robert JM
    Lancet; 1989 Mar; 1(8639):669. PubMed ID: 2564481
    [No Abstract]   [Full Text] [Related]  

  • 57. No improvement in delay in diagnosis of Duchenne muscular dystrophy.
    Marshall PD; Galasko CS
    Lancet; 1995 Mar; 345(8949):590-1. PubMed ID: 7605512
    [No Abstract]   [Full Text] [Related]  

  • 58. False elevation of amniotic fluid enzymes of relevance for prenatal diagnosis: creatine kinase measurement in relation to Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(1):35-42. PubMed ID: 6728825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muscular dystrophy screening.
    Drummond LM; Veale AM
    Lancet; 1978 Jun; 1(8076):1258-9. PubMed ID: 78018
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma phosphoglycerate mutase as a marker of muscular dystrophy.
    Chown PJ; Barnard EA; Barnard PJ; Liu PK; Carter ND
    J Neurol Sci; 1984 Aug; 65(2):201-10. PubMed ID: 6090594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.